The EAHP Board, elected for three-year terms, oversees the association’s activities. Comprising directors responsible for core functions, it meets regularly to implement strategic goals. Supported by EAHP staff, the Board controls finances, coordinates congress organization, and ensures compliance with statutes and codes of conduct.
Keynote 2 – Impact of Climate Change on Human Health: a resilient approach
Room:
Agora Plenary
Facilitator:
Daniele Mengato
Speakers:
Abstract:
Link to EAHP Statements
- Section 1 – Introductory Statement and Governance – 1.3
- Section 2 – Selection, Procurement and Distribution – 2.1, 2.2, 2.4, 2.5, 2.6
- Section 4 – Clinical Pharmacy services – 4.1, 4.3, 4.6, 4.7, 4.8
- Section 5 – Patient Safety and Quality Assurance – 5.1, 5.2, 5.5
- Section 6 – Education and Research: Statement Statements – 6.4
Abstract
Climate change is profoundly altering our daily lives. People around the world, in both high- and low-income countries, are increasingly feeling the impact of these changes on their health and well-being, reflecting the effects of continued dependence on fossil fuels. From an epidemiological perspective, climate-related environmental changes are associated with an increase in the incidence of chronic diseases already prevalent in the northern hemisphere, such as cardiovascular disease and mental illness, leading to increased use of related, heavily used western medications. Respirable, waterborne, and foodborne toxins and infections, including those transmitted by vectors, may become more prevalent in Western countries, Central and Eastern Asia and North America. As new disease threats arise, there is a growing need for the development of effective medications and treatments. This can drive scientific and pharmaceutical advancements, leading to the discovery of new drugs and therapies that can address not only climate-related diseases but also existing health conditions.
Furthermore, a “horizon scanning” approach can be a powerful tool for identifying potential future health challenges and preparing appropriate responses. By proactively anticipating these problems, we can allocate resources, enhance preparedness, and invest in research and development to address emerging health threats. This approach should help all of us, including hospital pharmacists, to stay ahead of the curve and mitigate the potential impact of climate change on our health.
Learning objectives
After the keynote, the participant should be able to:
- List the possible diseases that could arise as a result of climate change
- Identify climate change-related risks to access to medicine
- List strategies to address the emerging threats related to climate change
Educational need addressed
Climate change has a known impact on health and present and future diseases. Hospital Pharmacists should be able to discuss the issues related to these aspects, with a particular focus on the challenges related to medication management.
Keywords
Environmental aspects, drug shortage, healthcare reform, leadership, education